Evidence map›Paper›PMID 36845117›Full record

ArticleFrontiers in immunology2023

Specific

Duncan C Humphries, Richard A O'Connor, Hazel L Stewart, Tom M Quinn, Erin E Gaughan, Beth Mills, Gareth O S Williams, James M Stone, Keith Finlayson, Martine Chabaud-Riou and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Duncan C HumphriesTranslational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Richard A O'ConnorTranslational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Hazel L StewartTranslational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Tom M QuinnTranslational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Erin E GaughanTranslational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Beth MillsTranslational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Gareth O S WilliamsTranslational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
James M StoneTranslational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Keith FinlaysonTranslational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Martine Chabaud-RiouResearch & Development, Sanofi, Marcy L'Etoile, France.
Florence BoudetResearch & Development, Sanofi, Marcy L'Etoile, France.
Kevin DhaliwalTranslational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Vincent PavotResearch & Development, Sanofi, Marcy L'Etoile, France.
University of Edinburgh · GBCentre for Inflammation Research · GBGenoscience Pharma (France) · FRQueen's Medical Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pulmonary-resident memory T cells (T Methods: To address this need, we developed a novel Results: Initially, cells from human lung digests (confirmed to contain T Discussion:

Indexed as

Immunologic MemoryLungCD8-Positive T-LymphocytesHumansLymphocytesfluorescence lifetime imaginglungoptical endomicroscopyresident memory B cellsresident memory T cells

Identifiers

PMID36845117
PMCPMC9951616
OpenAlexW4319959447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.